Sindrome mielodisplastica, Santini (UniFi): "Luspatercept efficace in 60% casi"
Posted inBusiness News Entrepreneurship Investments Startups Stock Market Uncategorized

Sindrome mielodisplastica, Santini (UniFi): "Luspatercept efficace in 60% casi"

No Comments


(Adnkronos) – Sull’estensione di indicazioni: “Libertà da trasfusioni per 12 settimane che può mantenersi per anni”

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *